IL17A and metabolic dysfunction-associated steatotic liver disease: As Th17 cell and IL-17 have been reported to improve the intestinal barrier and host MetS, we speculate that intestinal Th17 cells and IL-17 may play a protective role in the progression of NASH and NAFLD [13, 188, 189].